1. Home
  2. CRESY vs SGP Comparison

CRESY vs SGP Comparison

Compare CRESY & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$10.88

Market Cap

804.3M

Sector

Finance

ML Signal

HOLD

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

HOLD

Current Price

$28.04

Market Cap

799.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRESY
SGP
Founded
1936
2019
Country
Argentina
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
804.3M
799.4M
IPO Year
1997
2026

Fundamental Metrics

Financial Performance
Metric
CRESY
SGP
Price
$10.88
$28.04
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$15.86
★ $44.00
AVG Volume (30 Days)
★ 205.6K
71.6K
Earning Date
11-09-2026
11-10-2026
Dividend Yield
★ 5.46%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.96
N/A
Revenue Next Year
$19.02
N/A
P/E Ratio
$6.92
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.30
$17.06
52 Week High
$14.21
$32.44

Technical Indicators

Market Signals
Indicator
CRESY
SGP
Relative Strength Index (RSI) 37.88 61.75
Support Level $10.52 $24.85
Resistance Level $11.74 $29.92
Average True Range (ATR) 0.40 1.36
MACD -0.08 0.38
Stochastic Oscillator 1.75 97.82

Price Performance

Historical Comparison
CRESY
SGP

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: